133 related articles for article (PubMed ID: 22410782)
21. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
[TBL] [Abstract][Full Text] [Related]
22. Reduction of metastasis, cell invasion, and adhesion in mouse osteosarcoma by YM529/ONO-5920-induced blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathway.
Tsubaki M; Satou T; Itoh T; Imano M; Ogaki M; Yanae M; Nishida S
Toxicol Appl Pharmacol; 2012 Mar; 259(3):402-10. PubMed ID: 22326785
[TBL] [Abstract][Full Text] [Related]
23. K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling.
Campbell PM; Groehler AL; Lee KM; Ouellette MM; Khazak V; Der CJ
Cancer Res; 2007 Mar; 67(5):2098-106. PubMed ID: 17332339
[TBL] [Abstract][Full Text] [Related]
24. CrkL plays a role in SDF-1-induced activation of the Raf-1/MEK/Erk pathway through Ras and Rac to mediate chemotactic signaling in hematopoietic cells.
Arai A; Aoki M; Weihua Y; Jin A; Miura O
Cell Signal; 2006 Dec; 18(12):2162-71. PubMed ID: 16781119
[TBL] [Abstract][Full Text] [Related]
25. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of Raf-1 signaling by a monoclonal antibody, which interferes with Raf-1 activation and with Mek substrate binding.
Kolch W; Philipp A; Mischak H; Dutil EM; Mullen TM; Feramisco JR; Meinkoth JL; Rose DW
Oncogene; 1996 Sep; 13(6):1305-14. PubMed ID: 8808705
[TBL] [Abstract][Full Text] [Related]
27. Analysis of the K-ras/B-raf/Erk signal cascade, p53 and CMAP as markers for tumor progression in colorectal cancer patients.
Georgieva M; Krasteva M; Angelova E; Ralchev K; Dimitrov V; Bozhimirov S; Georgieva E; Berger MR
Oncol Rep; 2008 Jul; 20(1):3-11. PubMed ID: 18575712
[TBL] [Abstract][Full Text] [Related]
28. Membrane recruitment of Raf-1 is not the only function of Ras in Raf-1 activation.
Tamada M; Hu CD; Kariya K; Okada T; Kataoka T
Oncogene; 1997 Dec; 15(24):2959-64. PubMed ID: 9416839
[TBL] [Abstract][Full Text] [Related]
29. Interactions between the PI3K and Raf signaling pathways can result in the transformation of hematopoietic cells.
McCubrey JA; Lee JT; Steelman LS; Blalock WL; Moye PW; Chang F; Pearce M; Shelton JG; White MK; Franklin RA; Pohnert SC
Cancer Detect Prev; 2001; 25(4):375-93. PubMed ID: 11531015
[TBL] [Abstract][Full Text] [Related]
30. Two transforming C-RAF germ-line mutations identified in patients with therapy-related acute myeloid leukemia.
Zebisch A; Staber PB; Delavar A; Bodner C; Hiden K; Fischereder K; Janakiraman M; Linkesch W; Auner HW; Emberger W; Windpassinger C; Schimek MG; Hoefler G; Troppmair J; Sill H
Cancer Res; 2006 Apr; 66(7):3401-8. PubMed ID: 16585161
[TBL] [Abstract][Full Text] [Related]
31. Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1.
Sasaki A; Taketomi T; Kato R; Saeki K; Nonami A; Sasaki M; Kuriyama M; Saito N; Shibuya M; Yoshimura A
Nat Cell Biol; 2003 May; 5(5):427-32. PubMed ID: 12717443
[TBL] [Abstract][Full Text] [Related]
32. TG-interacting factor-induced superoxide production from NADPH oxidase contributes to the migration/invasion of urothelial carcinoma.
Huang HS; Liu ZM; Chen PC; Tseng HY; Yeh BW
Free Radic Biol Med; 2012 Aug; 53(4):769-78. PubMed ID: 22728270
[TBL] [Abstract][Full Text] [Related]
33. Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2).
Koong AC; Chen EY; Mivechi NF; Denko NC; Stambrook P; Giaccia AJ
Cancer Res; 1994 Oct; 54(20):5273-9. PubMed ID: 7923153
[TBL] [Abstract][Full Text] [Related]
34. Specific association of activated MAP kinase kinase kinase (Raf) with the plasma membranes of ras-transformed retinal cells.
Traverse S; Cohen P; Paterson H; Marshall C; Rapp U; Grand RJ
Oncogene; 1993 Nov; 8(11):3175-81. PubMed ID: 8414521
[TBL] [Abstract][Full Text] [Related]
35. Site-specific phosphorylation of raf in cells containing oncogenic ras-p21 is likely mediated by jun-N-terminal kinase.
Adler V; Bowne W; Michl J; Sookraj KA; Ikram K; Pestka S; Izotova L; Zenilman M; Friedman FK; Qu Y; Pincus MR
Ann Clin Lab Sci; 2008; 38(1):47-56. PubMed ID: 18316782
[TBL] [Abstract][Full Text] [Related]
36. PTPLAD1 Regulates PHB-Raf Interaction to Orchestrate Epithelial-Mesenchymal and Mitofusion-Fission Transitions in Colorectal Cancer.
Huang ZJ; Li YJ; Yang J; Huang L; Zhao Q; Lu YF; Hu Y; Zhang WX; Liang JZ; Pan J; Pan YL; He QY; Wang Y
Int J Biol Sci; 2024; 20(6):2202-2218. PubMed ID: 38617530
[TBL] [Abstract][Full Text] [Related]
37. Prohibitin (PHB) interacts with AKT in mitochondria to coordinately modulate sperm motility.
Li XH; Chai RR; Chen GW; Zhang LF; Tan-Tai WJ; Shi HJ; Martin-DeLeon PA; O WS; Chen H
Asian J Androl; 2020; 22(6):583-589. PubMed ID: 32859869
[TBL] [Abstract][Full Text] [Related]
38. Akt phosphorylates Prohibitin 1 to mediate its mitochondrial localization and promote proliferation of bladder cancer cells.
Jiang L; Dong P; Zhang Z; Li C; Li Y; Liao Y; Li X; Wu Z; Guo S; Mai S; Xie D; Liu Z; Zhou F
Cell Death Dis; 2015 Feb; 6(2):e1660. PubMed ID: 25719244
[TBL] [Abstract][Full Text] [Related]
39. Prohibitin - At the crossroads of obesity-linked diabetes and cancer.
Mishra S; Nyomba BG
Exp Biol Med (Maywood); 2017 Jun; 242(11):1170-1177. PubMed ID: 28399645
[TBL] [Abstract][Full Text] [Related]
40. Prohibitins role in cellular survival through Ras-Raf-MEK-ERK pathway.
Chowdhury I; Thompson WE; Thomas K
J Cell Physiol; 2014 Aug; 229(8):998-1004. PubMed ID: 24347342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
